在心力衰竭中,脱氧化α-tubulin调解了线粒体功能障碍和心脏扩张功能障碍

相关实验视频

Updated: Sep 9, 2025

10:53

Author Spotlight: Mitochondrial Remodeling in Skeletal Muscle

Published on: December 1, 2023

3.7K

Shunsuke Miura¹, Tomofumi Misaka^1,2, Toranosuke Sekine¹

¹Department of Cardiovascular Medicine, Fukushima Medical University, Fukushima, Japan.

FEBS letters

|August 29, 2025

概括

在心力衰竭中,脱氧化氨酸会导致线粒体功能障碍和线粒体衰竭 (HFpEF). 针对这种机制可能为HFpEF提供新的治疗策略.

科学领域:

心血管生物学
分子细胞生物学
线粒体医学

背景情况:

心脏衰竭与保存的喷射分数 (HFpEF) 具有扩张功能障碍的特征.
在HFpEF背后的精确分子机制仍然不完全理解.
线粒体功能障碍和线粒体衰竭与HFpEF的发病有关.

研究的目的:

为了研究对HFpEF的阿尔法素的作用.
阐明HFpEF中α-tubulin obligaosination,线粒体功能和线粒体衰变之间的分子联系.
确定HFpEF的潜在治疗点.

主要方法:

使用SAUNA诱导的HFpEF小鼠模型.
使用H9c2心肌细胞实验与VASH1过度表达和氨酸酶淘汰.
评估了线粒体呼吸,线粒体的标志物 (帕金素招募,VDAC1无处不在),以及心脏功能.

主要成果:

在HFpEF模型中,增高的静脉激素-1 (VASH1) 表达与增高的异酸氨酸相关.
增加的阿尔法素减少了线粒体呼吸,并通过损害帕金素招募抑制了线粒体吸血.
心脏特异性VASH1表达诱导了HFpEF类表型,包括腹功能障碍和线粒体活性降低.

结论:

在HFpEF中,阿尔法- 氨酸异常是线粒体功能障碍和线粒体细胞衰竭的关键因素.
在HFpEF病变发生过程中,VASH1- 脱氨酸的α- 氨酸轴是一个新的途径.
针对alpha- tubulin异化为HFpEF提供了一个潜在的治疗策略.

关键词:

心脏衰竭与保存的喷射分数线粒体细胞分裂维索希宾 1 种氨酸的排毒

相关概念视频

01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...

01:17

Pathophysiology of Heart Failure

1.8K

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...

1.8K

01:22

Heart Failure Drugs: Diuretics

483

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...

483

01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...

01:26

Heart Failure Drugs: Inotropic Agents

717

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...

717

01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...